SCHEMBL12523328

SCHEMBL12523328

CCN1C[C@@H](N)C2(CC2)C1

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.38
JAK1 P23458 1/20 0.38
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12523302 1.00 JAK2 (0.38) JAK2JAK1TSHR
SCHEMBL12523343 1.00 JAK2 (0.38) JAK2JAK1TSHR
SCHEMBL22778844 0.83 JAK2 (0.34) JAK2JAK1
SCHEMBL22855610 0.81 TSHR (0.34) TSHR
SCHEMBL22752293 0.78
SCHEMBL22752505 0.78
SCHEMBL12524851 0.75
SCHEMBL12524324 0.74 JAK2 (0.33) JAK2JAK1TSHR
SCHEMBL16330608 0.74 JAK2 (0.33) JAK2JAK1TSHR
SCHEMBL12523410 0.74 JAK2 (0.33) JAK2JAK1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3012258-A1 PYRAZOLO[1,5-A]PYRIMIDINES AND -TRIAZINES AS ANTIVIRAL AGENTS Gilead Sciences, Inc. (US) 2016-04-27 EP disclosed
EP-2585467-B1 PYRAZOLO[1,5-A]PYRIMIDINES AND -TRIAZINES AS ANTIVIRAL AGENTS GILEAD SCIENCES INC (US) 2016-03-02 EP disclosed